![Hendrik-Tobias Arkenau](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hendrik-Tobias Arkenau
Fondatore presso Sarah Cannon Research Institute UK Ltd.
Posizioni attive di Hendrik-Tobias Arkenau
Società | Posizione | Inizio | Fine |
---|---|---|---|
Sarah Cannon Research Institute UK Ltd.
![]() Sarah Cannon Research Institute UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of HCA Healthcare, Inc., Sarah Cannon Research Institute UK Ltd. is an innovative clinical trial facility based in London, UK. SCRI is at the forefront of developing new cancer therapies and precision cancer treatment, and offers clinical trials for those interested in participating. The British company was founded in 1993 by Hendrik-Tobias Arkenau. The CEO is Dee Anna Smith. | Direttore Tecnico/Scientifico/R&S | 01/01/1993 | - |
Fondatore | 01/01/1993 | - |
Storia della carriera di Hendrik-Tobias Arkenau
Statistiche
Distribuzione geografica
Regno Unito | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Settori
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Sarah Cannon Research Institute UK Ltd.
![]() Sarah Cannon Research Institute UK Ltd. Miscellaneous Commercial ServicesCommercial Services Part of HCA Healthcare, Inc., Sarah Cannon Research Institute UK Ltd. is an innovative clinical trial facility based in London, UK. SCRI is at the forefront of developing new cancer therapies and precision cancer treatment, and offers clinical trials for those interested in participating. The British company was founded in 1993 by Hendrik-Tobias Arkenau. The CEO is Dee Anna Smith. | Commercial Services |